Most Recent Articles about TEVA
Teva launches Rituxan biosimilar in U.S. https://seekingalpha.com/news/3568193-teva-launches-rituxan-biosimilar-in-u-s?source=feed_sector_healthcare May 04, 2020 - Teva Pharmaceutical Industries (NYSE:TEVA) and collaboration partner Celltrion Healthcare announce the commercial availability of Truxima (rituximab-abbs), a biosimilar to Roche's (OTCQX:RHHBY) Rituxa
Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know http://www.zacks.com/stock/news/897134/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-897134 Apr 28, 2020 - In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $10.84, marking a +1.12% move from the previous day.
Eagle Pharma and Teva prevail in Bendeka patent challenge https://seekingalpha.com/news/3565267-eagle-pharma-and-teva-prevail-in-bendeka-patent-challenge?source=feed_sector_healthcare Apr 28, 2020 - Eagle Pharmaceuticals (NASDAQ:EGRX) and licensee Teva Pharmaceutical Industries (NYSE:TEVA) announce a favorable outcome in a patent dispute from would-be generic competitors to blood cancer med Bende